Proteos
Mary Shuck began their career as a Research Technician at St. Jude Children's Research Hospital in 1983. Mary then joined Pfizer in 1987 as a Research Scientist and eventually became a Principal Scientist, where they contributed to lead discovery in cardiovascular diseases and cell and molecular biology. In 2009, Mary joined Proteos as the Director of Protein Expression and was responsible for overseeing protein expression projects and managing client relationships. In 2018, they were promoted to President of Proteos, where they led business development and implemented client-relationship management tools. Mary currently serves as the Chief Executive Officer of Proteos since 2022.
Mary Shuck attended Bethel University from 1980 to 1983, where they earned a Bachelor of Science degree in Biology.
This person is not in any teams
Proteos
Proteos is committed to providing a quality foundation for drug discovery. They are a contract research organization that provides the highest quality recombinant protein expression and purification services for drug discovery research in the biotechnology and pharmaceutical industries.They service to Contract Research Services, AntibodyProduction, Recombinant Protein Production, Protein Analytics, Protein Expression, Assay Services, Protein Purification, Custom Cell Culture.